DPPA5

DPPA5 is a eutherian-specific KH-domain RNA-binding protein restricted to pluripotent stem cells and germ cells, where it acts to buffer cellular stress and reinforce the pluripotency network (PMID:17913455, PMID:24882002). In hematopoietic stem cells it lowers endoplasmic reticulum stress and apoptosis, with gain of function enhancing reconstitution capacity and knockdown impairing long-term reconstitution through elevated ER stress (PMID:24882002). In pluripotent cells it physically binds NANOG and stabilizes the protein post-transcriptionally—raising NANOG protein without changing its mRNA—thereby promoting pluripotency and reprogramming efficiency (PMID:26661329). DPPA5 abundance is itself controlled by the E3 ubiquitin ligase FBXO9, which targets it for proteasomal degradation; relieving this degradation facilitates induction of pluripotency (PMID:38227647). Its tissue-restricted expression is enforced by promoter CpG island methylation, with silencing in somatic tissues reversed by demethylation or loss of DNMT1/DNMT3b (PMID:17967063). Despite this expression pattern, genetic ablation in mouse shows DPPA5 is dispensable for ES cell self-renewal and germ cell development under normal conditions (PMID:16504174).

1. 2006 High

   Established whether DPPA5, despite its highly specific expression, is genetically required for the pluripotent and germ cell compartments where it is found.

   Evidence Homologous recombination knockout of mouse Esg1/Dppa5 in ES cells and mice with phenotypic characterization

   PMID:16504174

   Open questions at the time

   • Does not test redundancy with paralogous KH-domain family members
   • No challenge or stress condition tested where loss might manifest a phenotype
2. 2007 Medium

   Defined how DPPA5's restriction to germline/pluripotent tissues is enforced, identifying promoter CpG methylation as the silencing mechanism in soma.

   Evidence Bisulfite sequencing, demethylating agent, and DNMT1/DNMT3b-deficient cell analysis

   PMID:17967063

   Open questions at the time

   • Does not identify the transcription factors driving expression in unmethylated states
   • Functional role of expressed protein not addressed
3. 2007 Medium

   Placed DPPA5 in a defined molecular class by showing it carries an atypical KH RNA-binding domain shared across a eutherian-specific oocyte/ES-cell gene family.

   Evidence Sequence and domain analysis with expression profiling across family members

   PMID:17913455

   Open questions at the time

   • RNA-binding activity not directly demonstrated
   • No RNA targets identified
4. 2008 Low

   Localized the endogenous protein, establishing nuclear residence in pluripotent cells and the existence of N-terminally acetylated and unmodified isoforms.

   Evidence Subcellular fractionation with 2D gel and mass spectrometry of mouse ES/EG cell nuclear proteome

   PMID:18449859

   Open questions at the time

   • Single-lab proteomics without functional follow-up
   • Significance of acetylated isoform unknown
   • Does not exclude cytoplasmic pools
5. 2014 High

   Assigned a cellular function by linking DPPA5 to ER stress control and stem cell maintenance beyond the pluripotent compartment.

   Evidence Reciprocal overexpression/knockdown in HSCs with ER stress, apoptosis, and in vivo reconstitution readouts plus chemical chaperone rescue

   PMID:24882002

   Open questions at the time

   • Molecular mechanism connecting DPPA5 to the unfolded protein response not resolved
   • Direct RNA or protein effectors in the ER stress pathway not identified
6. 2015 Medium

   Identified a direct molecular partner and mechanism, showing DPPA5 stabilizes NANOG protein to reinforce pluripotency.

   Evidence Co-immunoprecipitation, protein stability assays, and qRT-PCR in human PSCs with reprogramming readouts

   PMID:26661329

   Open questions at the time

   • Domain mediating the DPPA5-NANOG interaction not mapped
   • Mechanism of stabilization (e.g., blocking degradation) not defined
   • Reciprocal validation in additional systems absent
7. 2017 Low

   Extended DPPA5 localization to a stress-responsive compartment, identifying it as a stress granule component upon oxidative and heat stress.

   Evidence Immunofluorescence co-localization with SG markers in hiPSCs under arsenite and heat shock

   PMID:28746394

   Open questions at the time

   • Single co-localization method without functional consequence tested
   • Relationship to its ER stress role unclear
8. 2024 Medium

   Defined how DPPA5 protein levels are regulated, identifying FBXO9-mediated ubiquitylation and proteasomal turnover as a control point during reprogramming.

   Evidence RNAi screen during reprogramming with FBXO9 silencing and DPPA5 protein/pluripotency readouts

   PMID:38227647

   Open questions at the time

   • No in vitro ubiquitylation reconstitution to prove direct ligase activity
   • Ubiquitylation site on DPPA5 not mapped

• Whether DPPA5's RNA-binding KH domain has bona fide RNA targets that mechanistically connect its roles in ER stress buffering, NANOG stabilization, and stress granule recruitment remains unresolved.
• No direct RNA targets identified
• Unifying biochemical mechanism across phenotypes not established
• Whether nuclear, stress granule, and stabilizing functions reflect distinct activities is unknown